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Chronic Expression of Interferon-
Gamma Leads to Murine Autoimmune
Cholangitis With a Female Predominance
Heekyong R. Bae,1 Patrick S.C. Leung,2 Koichi Tsuneyama,3 Julio C. Valencia,1 Deborah L. Hodge,1 Seohyun Kim,1 Tim Back,1
Megan Karwan,4 Anand S. Merchant,5 Nobuyuki Baba,6 Dechun Feng,7 Ogyi Park,8 Bin Gao,7 Guo-Xiang Yang,2
M. Eric Gershwin,2 and Howard A. Young1
In most autoimmune diseases the serologic hallmarks of disease precede clinical pathology by years. Therefore, the use of ani-
mal models in defining early disease events becomes critical. We took advantage of a “designer” mouse with dysregulation of
interferon gamma (IFNc) characterized by prolonged and chronic expression of IFNc through deletion of the IFNc 30-
untranslated region adenylate uridylate-rich element (ARE). The ARE-Del-/- mice develop primary biliary cholangitis (PBC)
with a female predominance that mimics human PBC that is characterized by up-regulation of total bile acids, spontaneous pro-
duction of anti-mitochondrial antibodies, and portal duct inflammation. Transfer of CD4 T cells from ARE-Del-/- to B6/
Rag1-/- mice induced moderate portal inflammation and parenchymal inflammation, and RNA sequencing of liver gene expres-
sion revealed that up-regulated genes potentially define early stages of cholangitis. Interestingly, up-regulated genes specifically
overlap with the gene expression signature of biliary epithelial cells in PBC, implying that IFNc may play a pathogenic role in
biliary epithelial cells in the initiation stage of PBC. Moreover, differentially expressed genes in female mice have stronger type
1 and type 2 IFN signaling and lymphocyte-mediated immune responses and thus may drive the female bias of the disease.Con-
clusion:Changes in IFNc expression are critical for the pathogenesis of PBC. (HEPATOLOGY 2016;64:1189-1201)
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A
s with most autoimmune diseases, primary bil-
iary cholangitis (PBC) is female-predominant
and has a long latency period between detec-
tion of autoantibodies and the clinical appearance of
immunopathology.(1-4) Although there are clearly major
defects in adaptive immunity, including dysregulation of
multiple T-cell and B-cell pathways,(5-11) there is signif-
icant evidence for the role of innate immunity in modu-
lating and perhaps even initiating disease activity.(12-17)
Indeed, we have proposed that PBC is a multihit disease
involving independent but overlapping immune path-
ways that interact at different stages of disease activity,
ultimately leading to the clinical entity of severe portal
inflammation with potential cirrhosis.
The role of interferon (IFN) in autoimmunity is contro-
versial, but a T-helper 1 (Th1) cell-mediated inflammatory
response appears critical for loss of tolerance. In the present
study, we took advantage of a mouse in which there is a
deletion of the IFN 30-untranslated region adenylate
uridylate-rich element, resulting in chronic IFN expres-
sion, and report here that these mice not only develop the
classic histologic features of autoimmune cholangitis but,
more importantly, have a gender-differential bias as well as
characteristic dysregulation of bile acids. We propose that
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The generation of this strain has been described,(18)
and the phenotype has been described as including a
mild lupus-like disease. However, we observed that sera
from older mice appeared fatty, and this led to the stud-
ies reported herein; two ARE-Del lines, derived from
individual embryonic stem cell clones, were selected and
backcrossed at least 10 generations onto C57BL/6
mice. After backcrossing, the genetic backgrounds were
assessed at the DartMouse Speed Congenic Core Facil-
ity at the Geisel School of Medicine at Dartmouth.
Animal care was provided in accordance with the proce-
dures outlined in the “Guide for Care and Use of Labo-
ratory Animals” (National Research Council, 2011).
HISTOPATHOLOGY
Detailed protocols of hematoxylin and eosin (H&E)
staining, sirius red staining, Fontana-Masson staining, and
histological scoring are described in the Supporting
Information.
DETECTION OF SERUM ANTI-
MITOCHONDRIAL ANTIBODIES
Serum anti-mitochondrial antibodies (AMA) were
detected using our standard enzyme-linked immuno-
sorbent assay against recombinant proteins of the pyru-
vate dehydrogenase complex E2 subunit (PDC-E2),
branched chain 2-oxo-acid dehydrogenase E2 subunit
(BCOADC-E2), and 2-oxo-glutararte dehydrogenase
E2 subunit (OGDC-E2).(19)
TOTAL BILE ACID ANALYSIS
Total bile acids (TBA) were analyzed using freshly
collected serum and the Total Bile Acid Enzymatic
Cycling Assay Kit (Diazyme, Poway, CA), according
to the manufacturer’s protocols with modifications as
described in the Supporting Information.
RNA SEQUENCING
Detailed protocols, including messenger RNA prep-
aration, library construction, Illumina HiSeq2500
sequencing, and data processing, are described in the
Supporting Information. The data set is available in
the National Center for Biotechnology Information/
Gene Expression Omnibus (GSE76309).
ADOPTIVE CELL TRANSFER
Spleen cells were collected from 20-week-old female
ARE-Del-/- mice. Mononuclear cells were isolated,
and CD41 or CD81 T cells were purified by positive
selection with microbeads and MiniMacs separation
columns. Ten-week-old female B6/Rag1-/- mice were
used as recipients. CD41 T cells, CD81 T cells, or
whole spleen mononuclear cells (1 3 106) were trans-
ferred into recipient mice by tail vein injection.
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At 20 weeks after cell transfer, mice were sacrificed
and livers were collected for H&E staining. The histo-
pathology was graded as no inflammation (or bile duct
damage), minimal inflammation (or bile duct damage),
mild inflammation (or bile duct damage), moderate
inflammation (or bile duct damage), and severe inflam-
mation (or bile duct damage). Levels of IFN, tumor
necrosis factor (TNF), interleukin-6 (IL-6), and
monocyte chemoattractant protein-1 (MCP-1) in
serum of recipient mice were measured with a cytokine
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FIG. 1. Liver histology in ARE-Del-/-
mice. (A) Representative H&E staining
of male and female ARE-Del-/- mice.
Arrows point to the inflammatory foci
region. (B) Representative H&E staining
of portal inflammation (arrow: bile duct
showing mild damage), lobular inflamma-
tion (arrow: focal necrosis), biliary duct
damage (arrow: bile duct showing moder-
ate damage), and granuloma formation
(arrow: epithelioid granuloma in portal
tract) in female ARE-Del-/- mice. (C)
Statistical analysis of liver histology of
male and female ARE-Del-/- mice was
performed by the nonparametric Mann-
Whitney test using GraphPad Prism 6.0
(mean 6 standard error of the mean, n 5
16 from three independent experiments).
The two-tailed P value <0.05 was taken
as significant (*P < 0.05, **P < 0.01, ***P
< 0.001). (D) Representative sirius red
staining of liver fibrosis in female ARE-
Del-/- mice at age 20 weeks. Scale bars 5
200 lm (A), 50 lm (B) and 100 lm (D).
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ARE-DEL-/- MICE WITH FEMALE
DOMINANCE
Hepatic lesions from 20-week-old female ARE-Del-/-
mice were noted to have moderate to severe portal lymph-
oid cell infiltration, whereas male ARE-Del-/- had only
mild to moderate infiltration (Fig. 1A). Furthermore,
portal and lobular inflammation, small bile duct destruc-
tion, and granuloma formation were more severe in
female ARE-Del-/- mice (Fig. 1B). We further assessed
the severity of these hepatic lesions based on unbiased
quantification of frequency (Fig. 1C). A Mann-Whitney
statistical analysis of all ages of mice (8-10 weeks old n 5
4, 19-24 weeks n 5 8, over 40 weeks n 5 4) demon-
strated that female ARE-Del-/- mice had higher frequen-
cies of lymphocyte infiltration, damaged bile ducts, and
granulomas than male ARE-Del-/- mice. Bile duct
destruction correlated with age, indicating that bile duct
damage occurs at a later stage of progression (Supporting
Fig. S1). Based on sirius red staining (Fig. 1D), mild
fibrosis was observed in female ARE-Del-/- mice; the
severity of fibrosis was substantially lower or not detecta-
ble in male ARE-Del-/- mice (data not shown).
Both aspartate aminotransferase and alanine amino-
transferase levels were significantly increased in 20-
week-old female ARE-Del-/- mice, although not as
high as one finds in models of hepatitis.(20) Male ARE-
Del-/- mice had significant changes in the level of ala-
nine aminotransferase compared to control littermates,
but there were no significant changes in the level of
aspartate aminotransferase (Supporting Fig. S2). Con-
sidering that alanine aminotransferase is exclusively in
the cytoplasm while aspartate aminotransferase is in
both mitochondria and the cytoplasm, this result sug-
gests that female ARE-Del-/- mice may have critical
damage in the mitochondria of target cells.
FEMALE ARE-DEL-/- MICE
PRODUCE AMA
Female ARE-Del-/- mice, 8-10 weeks old, had
readily detectable antibodies to PDC-E2, BCOADC-
E2, and OGDC-E2 (Fig. 2A). These data were repli-
cated at 20 weeks of age (Fig. 2C). The dominant
autoantibody was directed to PDC-E2. In contrast,
male ARE-Del-/- mice, 8-10 weeks old, had detectable
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FIG. 1. Continued
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antibodies to PDC-E2 but no significant differences
from controls with respect to autoantibodies to
OGDC-E2 or BCOADC-E2 (Fig. 2B). Interestingly,
at 20 weeks of age, there were no significant detectable
AMA to any of the three epitopes in the male groups
compared to controls (Fig. 2D).
TBA ARE HIGHLY UP-
REGULATED IN FEMALE
ARE-DEL-/- MICE
Eight-week-old female ARE-Del-/- mice had a mild
elevation of TBA (25.8 6 3.67 lM, n 5 4). There were
no significant changes observed in male ARE-Del-/-
mice (Fig. 3A). In contrast, significantly higher levels of
TBA were observed in 20-week-old female ARE-Del-/-
mice (115.6 6 11.71 lM of mean 6 standard error of
the mean, n 5 8) versus control littermates (3.8 6 0.36
lM, n 5 9). Male ARE-Del-/- mice had relatively mild
induction of TBA (19.12 6 5.5 lM, n 5 8) compared
to control littermates (1.9 6 0.36 lM, n 5 8) (Fig. 3B).
Linear regression was performed to analyze the correla-
tion coefficient of the serum TBA with histological scores
of lymphocytic infiltration, bile duct damage, and granu-
loma formation. In 8-10 weeks, there was no correlation
between TBA and the histological scores (Supporting
Fig. S3A), whereas 20-week-old mice had relatively sig-
nificant correlations of TBA with portal inflammation
(r 5 0.79), lobular inflammation (r 5 0.76), bile duct
damage (r 5 0.80), and granuloma formation (r 5 0.91)
(Supporting Fig. S3B). Skin hyperpigmentation, a char-
acteristic feature of PBC, was increased in 20-week-old
female ARE-Del-/- mice (Fig. 3C), potentially through
inadequate bile flow due to bile duct destruction. Male
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FIG. 2. Levels of AMA in ARE-Del-/- mice. (A,B) Level of anti-
PDC-E2, anti-OGDC-E2, and anti-BCOADC-E2 in the serum of
female (A) and male (B) ARE-Del-/- at age 10 (62) weeks (n 5 4).
(C,D) Levels of anti-PDC-E2, anti-OGDC-E2, and anti-
BCOADC-E2 in the serum of female (C) and male (D) ARE-Del-/-
mice at age 20 (62) weeks (n 5 7-8). Data represent mean 6 stand-
ard error of the mean. Statistical analysis was performed by unpaired
Student t test. All data are representative of at least three independent
experiments. *P < 0.05; **P < 0.01; ***P < 0.001. Abbreviations:
n.s., not significant; O.D., optical density; WT, wild type.
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FIG. 3. Serum TBA levels in ARE-Del-/- mice. (A) Serum TBA
levels in female and male ARE-Del-/- mice at age 10 (62) weeks
(n 5 4). (B) Serum TBA levels in female and male ARE-Del-/-
mice at age 20 (62) weeks (n 5 7-8). Data represent mean 6 stand-
ard error of the mean. Statistical analysis was performed by unpaired
Student t test. * P < 0.05, **P < 0.01, ***P < 0.001. (C) Increased
tail skin pigmentation in female ARE-Del-/- mice. Scale bars 5 100
lm. All data are representative of at least three independent experi-
ments. Abbreviations: n.s., not significant; WT, wild type.
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ARE-Del-/- mice had mild or no increased skin hyper-
pigmentation, similar to that observed in ARE-Del1/-
heterozygotes. Overall, the level of TBA was correlated
with the level of skin pigmentation in both ARE-Del-/-





ARE-Del heterozygote mice have approximately 50%
the level of circulating IFN compared to homozygous
mice. We evaluated liver histology in heterozygous mice
compared to female ARE-Del-/- mice (Fig. 4A).
Although the overall image-based severity of hepatic
lesions of female ARE-Del1/- was less than that of
female ARE-Del-/- mice, the histological scores of
inflammatory regions indicated that female ARE-Del1/-
mice had portal tract lymphocytic infiltrates and biliary
duct lesions similar to female ARE-Del-/- mice. In con-
trast, male ARE-Del1/- mice had much lower severity
in lesions, consistent with the hypothesis that female
mice are more sensitive and/or amplify the IFN signaling
pathway compared to male mice (Fig. 4B,C). We further
analyzed serum AMA (Fig. 4D,E) and TBA (Fig. 4F)
of ARE-Del1/- mice. In 20-week-old mice, the level of
AMA was significantly up-regulated in female, but not
male, ARE-Del1/- mice, similar to that observed in
ARE-Del-/- mice. Serum levels of TBA were mildly
increased in female ARE-Del1/- mice and did not cor-
relate with histologic scores, unlike the above data on
female ARE-Del-/- mice (Supporting Fig. S3C).
GENE EXPRESSION SIGNATURES
IN ARE-DEL-/- MICE
A Venn diagram presentation of the data reflects that
female ARE-Del-/- mice have 1118 differentially expressed
genes compared to control littermates and that male
ARE-Del-/- mice have 288 differentially expressed genes
based on the criteria of greater than 62-fold changes and
a false discovery rate<0.05 (Fig. 5A). There are 258 genes
commonly overexpressed by female and male ARE-Del-/-
mice, demonstrating that the majority of genes from male
ARE-Del-/- mice are differentially expressed compared to
female ARE-Del-/- mice. A heat map generated from
these overlapping genes demonstrates that female ARE-
Del-/- mice have stronger expression of these genes (Fig.
5B). Considering that male ARE-Del-/- mice have only
mild to moderate pathology, these overlapping gene
expression patterns of both female and male ARE-Del-/-
mice suggest their involvement in the initiation of auto-
immune cholangitis. To explore the possible mechanism,
we performed a pathway analysis of these 258 genes using
Ingenuity Pathway Analysis (IPA). In this analysis, IFNc
(P value as 4.5 3 10-38) and the IFNa receptor (P value as
4.5 3 10-26) were observed as top upstream regulators,
while IFN signaling was more predominant in female
ARE-Del-/- mice (Fig. 5C). Consistent with gene expres-
sion data, we further confirmed higher levels of serum
IFNc in female versus male ARE-Del-/- mice (Supporting
Fig. S4). There was also significant stronger induction of
chemokines (monokine induced by IFNc, IFNc-inducible
protein 10, and macrophage inflammatory protein 1beta)
and cytokines (TNFa, IL-10, and IL-13) in female ARE-
Del-/-, whereas other cytokines and chemokines were not
significantly altered. The antigen presentation pathway
was detectable as a top canonical pathway for the 258 over-
lapping genes (Fig. 5D), and major histocompatibility
complex II (MHC-II) genes were the most highly
expressed genes in both male and female ARE-Del-/-
mice (Table 1), indicating that this pathway is likely critical




Gene expression analysis on liver biopsy tissues from
PBC patients indicated that IFNc signaling was signif-
icantly detectable in both early and late stages of dis-
ease.(21-23) Most of all, up-regulation of IFNc
signaling was more evident on chronic nonsuppurative
destructive cholangitis and biliary epithelial cell (BEC)
lesions dissected by laser capture microdissection. As
BECs are the target cells in PBC, we compared the
gene expression profile of this lesion with ARE-Del-/-
mice. Using the full list of genes in PBC-BEC lesions
biopsied from PBC patients (n 5 5) versus normal
subjects (n 5 3), we analyzed 78 differentially induced
genes and performed gene set enrichment analysis of
these genes in the human subject data using gene sets
from ARE-Del-/- mice. Notably, IFNc was detectable
as a top upstream regulator (P value as 4.2 3 10-29),
and there was a significant enrichment of the human
gene data in the data obtained from both male and
female ARE-Del-/- mice (Fig. 6A,B), suggesting that
IFNc may play a pathogenic role in BECs in the early
stage of PBC disease. Based on the similar expression
pattern of representative human genes (Supporting
Table S1), H2-Aa (human leukocyte antigen DQA1)
BAE ET AL. HEPATOLOGY, October 2016
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FIG. 4. Pathology of ARE-Del heterozygotes versus homozygotes. (A) Statistical analysis of female ARE-Del-/- mice (n 5 9 from
two independent experiments) versus ARE-Del1/- mice (n 5 23 from two independent experiments) with portal inflammation, lobu-
lar inflammation, biliary damage, and granuloma formation at age 20 weeks (mean 6 standard error of the mean), performed by non-
parametric Mann-Whitney test with a two-tailed p-value. (B) Representative H&E staining of male and female ARE-Del1/- mice at
age 20 weeks. Arrows point to the inflammatory foci region. Scale bars 5 200 lm (B left) and 50 lm (B right) (C) Statistical analysis
of liver histology of male and female ARE-Del1/- mice (n 5 20 6 2 from two independent experiments) was performed by Mann-
Whitney test with a two-tailed p-value. (D,E) Immunoglobulins G and M anti-PDC-E2 in male and female ARE-Del1/- mice at
age 20 weeks (mean 6 standard deviation, n 5 20 6 2). (F) Serum TBA in male and female ARE-Del1/- mice at age 20 weeks
(mean 6 standard deviation, n 5 20 6 2). (D-F) Statistical analysis was performed by unpaired Student t test.*P < 0.05, **P < 0.01,
***P < 0.001. Abbreviations: Het, heterozygote; IgG/IgM, immunoglobulins G and M; n.s., not significant; O.D., optical density;
WT, wild type.
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expression was one of most significantly induced genes
in ARE-Del-/- mice. It has been reported that the pro-
tein expression of human leukocyte antigen DQA1 was
highly increased in BEC lesions from PBC patients(24)
and that the MHC II locus was significantly associated
with susceptibility to PBC(25,26); thus, our data consis-
tently imply the importance of MHC class II expres-
sion in BECs for the initiation stage of PBC.
We performed IPA of 253 genes from Italian
patient cohorts selected by a pathway-based linear
combination test.(27) Remarkably, we identified IFNc as
the top upstream regulator (P value as 1.8 3 10215) in
these genes (Supporting Fig. S5). Furthermore, based
on recent genome-wide association studies
(GWASs),(24,28-30) we performed pathway analysis of
26 genes (Supporting Table S2) that have the most sig-
nificant variants (P value  1 3 10-5), selected by the
National Human Genome Research Institute GWAS
Catalog.(31) Twenty-one among the 26 genes were con-
nected to IFNc-mediated signaling, and IFNc was also
consistently detectable as the top upstream regulator (P
value as 8.7 3 10-9) as core networks were generated
(Fig. 6C). Among the top canonical pathways of these
genes, Th-cell differentiation, dendritic cell maturation,
and B-cell development were identified as highly signifi-
cant; and these pathways strongly overlapped with those
identified in female ARE-Del-/- mice (Fig. 6D). Target
DE genes from female ARE-Del-/- mice for each
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FIG. 5. Hepatic gene expression in male and female ARE-Del-/- mice at age 20 weeks. (A) Venn diagram of differentially expressed genes
in male and female ARE-Del-/- mice versus control mice (n 5 3). (B) Hierarchical clustering of 258 common genes. The human homologs
are described in parentheses. (C) Hierarchical clustering of 20 genes involved in the IFN signaling pathway. (D) Top canonical pathways of
common genes derived from IPA. Ratio (bottom y axis, yellow line) refers to the number of genes from the data set divided by the total
number of genes that make up that pathway from within the IPA knowledge base, and the -log of the P value (top y axis, bar) was calcu-
lated by Fisher’s exact test. Abbreviations: F, female; FDR, false discovery rate; HLA, human leukocyte antigen; M, male; WT, wild type.
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pathway are listed (Supporting Table S3), and their gene
networks also indicated Ifng, Ifnar, Tnf, Il-10, and Il-1b
as top upstream regulator genes. Moreover, Th cell-
mediated responses were specifically up-regulated in
these pathways, and immunohistochemical staining
with anti-CD4 and anti-CD8 antibodies consistently
showed higher CD4 infiltration in chronic nonsuppura-
tive destructive cholangitis lesions of female ARE-Del-/-
mice (Supporting Fig. S6). Thus, based on gene expres-
sion pathway analysis, the mouse model presented here
and the human disease strongly overlap.




Transfer of CD4 T cells from ARE-Del-/- mice to
B6/Rag1-/- mice induced moderate portal inflamma-
tion and mild parenchymal inflammation, while bile
duct damage and granuloma formation were minimally
induced (Fig. 7A). As the transfer of CD4 T cells pro-
duced similar histological phenotypes with that
observed upon transfer of whole spleen cells, CD4 T
cells may thus have a critical role in the pathological
progression observed in ARE-Del-/- mice. In contrast,
transfer of CD8 T cells resulted in minimal portal and
parenchymal inflammation with no visible effects on
bile ducts and no granuloma formation. The level of
serum IFN, TNF-a, IL-6, and MCP-1 were consis-
tently increased in mice receiving CD4 T cells or
whole spleen cells (Fig. 7B). In comparison mice
receiving CD8 T cells did not have significant induc-
tion of IFN, TNF-a and IL-6 compared with Rag1-/-
mice; and only MCP-1 was enhanced similar to what
was observed in mice receiving CD4 T cells.
Discussion
The data reported herein demonstrate that chronic
expression of IFNc leads to a classic PBC-like disease
with female gender dominance. A number of murine
spontaneous and induced models have been reported
that manifest features of human PBC.(25,26,32-38)
Clearly, no single model has fully mimicked the immu-
nopathophysiology of human PBC, and none hitherto
has exhibited female dominance. Immunologically,
PBC has long been recognized as reflective of Th1-
mediated autoimmunity. Our data indicate that the
Th17 pathway suppresses the accumulation of IFNc-
producing cells in liver during the early phase of chol-
angitis, also supporting the hypothesis that IFNc has a
pivotal role in the early events in autoimmune cholan-
gitis.(39) The expression of MHC in the liver is a major
canonical pathway seen in both male and female ARE-
Del-/- mice, indicating that IFNc is critical for early
stages of disease progression by enhancing MHC class
expression.
Similar to a wide spectrum of autoimmune diseases,
there is no convincing explanation or physiological
mechanisms that accounts for the strong female pre-
dominance in PBC.(40) Epidemiological studies in
PBC have suggested that frequent exposure to envi-
ronmental chemicals such as nail polish, chemicals
found in tobacco smoke, and use of hormone replace-
ment therapies are significantly associated with an
increased risk of PBC.(41) Other risk factors implicated
in female predominance of PBC include recurrent uri-
nary tract infection in females, use of exogenous estro-
gens, as well as an increased prevalence of reproductive
complications.(42,43) These risk factors may work syn-
ergistically in accelerating loss of tolerance. Thus, we
emphasize that it is not a genetic predisposition but
rather the pathology mediated through the interplay of
interferons as described above that results in disease
pathology. For example, one may postulate that during
infection or a chemical xenobiotic exposure there is a
transient and local up-regulation of IFN, which in the
genetically susceptible host will lead to loss of toler-
ance. Our data imply that these events may occur indi-
vidually over time, each leading to an up-regulation of
MHC on target tissue.
We focused on the female-specific pathways in
ARE-Del-/- mice to investigate the mechanisms
TABLE 1. Up-regulation of MHC Class I and II Genes
in ARE-Del-/- Mice
ARE-Del-/- (Male) ARE-Del-/- (Female)
MHC Gene P Fold P Fold
Class II Cd74 1.54 3 1025 44.5 6.26 3 1026 37.4
H2-DMa 3.64 3 1024 40.6 5.55 3 1025 33.7
H2-Aa 2.96 3 1024 34.1 7.95 3 1025 30.0
H2-Eb1 1.97 3 1024 27.0 1.69 3 1025 30.0
H2-Ab1 1.26 3 1024 21.1 1.48 3 1025 22.5
Class I H2-Q2 1.57 3 1026 23.7 3.0 3 1023 4.4
H2-Q8 2.95 3 1024 4.8 4.65 3 1025 3.9
H2-M3 9.19 3 1026 4.1 1.48 3 1027 4.3
H2-T10 1.69 3 1025 3.9 2.34 3 1025 2.6
H2-T23 8.59 3 1026 3.8 1.59 3 1026 3.2
H2-D1 7.44 3 1028 3.2 1.88 3 1028 3.1
H2-K1 4.89 3 1027 3.0 4.80 3 1027 2.5
H2-T24 9.70 3 1024 2.8 2.41 3 1024 2.0
H2-T22 2.90 3 1025 2.7 6.23 3 1026 2.4
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FIG. 6. Comparison of the gene expression profiling to human data from PBC patients. (A,B) Gene set enrichment analysis plots
for human DE genes in PBC-BEC lesions using gene sets of male (A) and female (B) ARE-Del-/- mice. (C) Top network identified
by IPA for the most significant 26 variants. The lines between genes represent known interactions (solid line for direct interaction,
dashed line for indirect interaction). (D) Canonical pathways of human GWAS with ARE-Del-/- mice. The most significant 26 var-
iants were selected by the National Human Genome Research Institute GWAS catalog (p  1 3 10-5). Top canonical pathways of
these genes were derived from IPA and compared with those from female ARE-Del-/- mice. “Ratio” (bottom y axis, yellow line) refers
to the number of genes from the data set divided by the total number of genes that make up that pathway from within the IPA
knowledge base, and the -log of the P value (top y axis, bar) was calculated by Fisher’s exact test. Abbreviations: FDR, false discovery
rate; FWER, family-wise error rate; iCOS/iCOSL, inducible costimulator/inducible costimulator ligand; NES, normalized enrichment
scores; NFAT, nuclear factor of activated T cells; PKC, protein kinase C.
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FIG. 7. Liver histopathology and level
of inflammatory cytokines in recipient
mice. (A) Pathological score of portal
inflammation, bile duct damage, granu-
loma, and parenchymal inflammation in
mice receiving CD41 T cells (n 5 6),
CD81 T cells (n 5 6), and whole spleen
cells (n 5 4). (B) Serum were collected
20 weeks after cell transfer; the levels of
IFN, TNF-a, IL-6, and MCP-1 in
mice receiving CD41 T cells (n 5 6),
CD81 T cells (n 5 6), and whole spleen
cells (n 5 4) were measured by a mouse
inflammatory cytokine cytometric bead
array kit. *P < 0.05, **P < 0.01, deter-
mined using the Kruskal-Wallis test
(nonparametric analysis of variance). All
data are representative of at least two
independent experiments. Abbreviations:
KO, knockout; MFI, mean fluorescence
intensity.
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involved in disease progression. Gene expression
analysis showed that the immune response was crit-
ically affected in female ARE-Del-/- mice, especially
in macrophages, dendritic cells, natural killer cells,
and T and B cells. Importantly, Th cell-mediated sig-
naling is one of the highly up-regulated pathways in
female, but not in male, ARE-Del-/- mice. Interest-
ingly, recent GWAS studies also point out that
potential PBC causing single-nucleotide variants was
enriched in CD4 T-cell signaling.(4) Of note, IL12-
Janus kinase-signal transducer and activator of tran-
scription 4 signaling in IL12-stimulated T cells may
drive gender-biased susceptibility to autoimmune dis-
eases due to enhanced Th1 responses as it has been
reported that estrogen causes increased phosphoryla-
tion of signal transducer and activator of transcription
4 in a nonobese diabetic mouse model.(44) Consistent
with our findings, CD4 T cells infiltrated in hepatic
inflammatory lesions based on analysis of PBC liver
biopsies,(4) and our cell transfer results also supported
the model that CD4 T cells are critical for pathologi-
cal progression of PBC. Therefore, our data suggest
that IFNc-induced Th1 response through CD4
T-cell activation drives the gender-biased progression
of PBC.
In summary, this work presents evidence for a path-
ogenic role of IFNc in the early stages and in the pro-
gression of PBC. Considering the prominence of a
female-specific bias in PBC disease progression, fur-
ther studies are necessary to investigate the mechanism
of sex-biased interferon signaling and its effect on
lymphocyte-mediated immune responses and on the
mechanisms involved in IFNc-mediated BEC death.
Such studies will lead to a rational approach toward
intervention and treatment of this chronic inflamma-
tory disease.
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